<ѻý>Pacemaker Interference Warning; Religious Fasting and CVD; Toothpick in the Heartѻý> Recent developments of interest in cardiovascular medicine May 17, 2021
<ѻý>Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedbackѻý> Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
<ѻý>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapyѻý> Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<ѻý>Mixed Results with ARNI Therapy for Post-MI Heart Failure Preventionѻý> Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
<ѻý>Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathyѻý> Secondary findings show big gains for more than a third of patients May 15, 2021
<ѻý>ARNI Therapy in the Hot Seat at Another Virtual ACCѻý> PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
<ѻý>COVID Vax & Myocarditis; Ejection Fractions on EKG; Southerners Still Unwellѻý> Recent developments of interest in cardiovascular medicine May 10, 2021
<ѻý>Surgical Repair: A Newcomer in Aortic Valve Diseaseѻý> In this podcast, Andrew Perry and Chris Burke tackle the current state of aortic valve repair May 07, 2021 podcast
<ѻý>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?ѻý> Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<ѻý>Farxiga Gets FDA Greenlight for CKDѻý> SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks Apr 30, 2021
<ѻý>Low Radiation Possible During Cardiac Cath in Childrenѻý> NYC center reports encouraging results with ALARA radiation protocol Apr 30, 2021
<ѻý>Endocarditis After Low-Risk TAVR: Different Trajectory, Problem Organismsѻý> Low-risk patients "not immune" to rare infection, LRT studies show Apr 30, 2021
<ѻý>Heart Pump Protocol Makes a Dent in Cardiogenic Shock Mortalityѻý> NCSI algorithm includes early hemodynamic support Apr 29, 2021
<ѻý>Post-MitraClip Gradients Not So Dangerous After Allѻý> COAPT analysis suggests benefit of MR reduction offsets risk of mitral stenosis Apr 19, 2021
<ѻý>CaMKII Inhibitor Disappoints in Post-MI Cardioprotectionѻý> First agent of its kind to test the waters in heart disease Apr 14, 2021
<ѻý>Donor Heart Preserver Survives Review by FDA Advisorsѻý> Panel had many bones to pick with the Transmedics OCS device Apr 07, 2021
<ѻý>Stripped of Hospital Privileges, St. Louis Cardiologists Go to Courtѻý> Suit against SSM Health seeks $50 million if former status not restored Apr 02, 2021
<ѻý>Harmony Pulmonary Valve Gets FDA Nodѻý> Transcatheter valve implantation approved for people without surgical RVOT conduits Mar 26, 2021
<ѻý>DOAC After Heart Valve Procedure?ѻý> Registry defines prevalent use with mechanical and bioprosthetic valves Mar 08, 2021
<ѻý>Pre-TAVR Leaflet Cut Backed by Registryѻý> BASILICA procedure for people at risk of coronary obstruction Mar 06, 2021
<ѻý>Universal Definition of Heart Failure Proposedѻý> U.S., European, and Japanese societies seek to standardize classifications Mar 02, 2021
<ѻý>Low-Risk TAVR at 2 Years: Thrombosis Concerns Creep Inѻý> PARTNER 3 showing trends toward convergence of outcomes with surgery Mar 01, 2021
<ѻý>White Bread or White Rice? Glycemic Index Telling of CVD Risk Across Bordersѻý> Observational study suggests role of diet in primary, secondary prevention alike Feb 24, 2021
<ѻý>Drinks, Drugs and Smokes Spell Early Heart Diseaseѻý> Amphetamines, cannabis, and cocaine posed the greatest ASCVD risk in the young Feb 16, 2021
<ѻý>First Drug Approved for Some HFpEFѻý> FDA doesn't set hard limits on ejection fraction in expanded indication Feb 16, 2021
<ѻý>Heart Failure Drug Tempers Heart Rate, Symptoms in POTSѻý> Promising results for people with hyperadrenergic subtype of the complex disorder Feb 16, 2021
<ѻý>HIIT for HFpEF? Results Mixed in Exercise Trialѻý> Boosting intensity not obviously helpful Feb 09, 2021
<ѻý>Nutrition Status Tied to TAVR Outcomesѻý> Data support pre- and post-TAVR dietary interventions for the elderly Feb 05, 2021
<ѻý>The Physical Exam: Mitral Regurgitationѻý> This podcast episode tackles ascultation, vein inspection, heart palpation, pulse, and more Feb 05, 2021 podcast
<ѻý>Promising Tissue Valve Tech Blocks Calcium Buildupѻý> Zero structural valve deterioration at 5 Years in the COMMENCE study Feb 01, 2021
<ѻý>Some of Last Year's Deferred Cardiac Surgeries Likely Still in Backlogѻý> Report describes effect of COVID on surgical case volumes, outcomes Jan 31, 2021
<ѻý>Combined Cath Approach No Match for Surgery for Aortic Stenosis, CADѻý> Pacemakers increasingly an issue in TAVR plus PCI Jan 30, 2021
<ѻý>CMS Expands MitraClip Coverage by Medicareѻý> Transcatheter mitral valve repair for secondary mitral regurgitation can now be reimbursed Jan 20, 2021
<ѻý>Ventricular Tachycardia: The Cause Is the Key to Managementѻý> Andrew Perry, MD, tackles the heterogeneity of VT with Melissa Robinson, MD Jan 15, 2021 podcast
<ѻý>Growth Hormones in Childhood Tied to Heart Problems Later Onѻý> Women, those who were small for gestational age at highest risk Dec 21, 2020
<ѻý>LVAD Approved for Childrenѻý> FDA clears the way for HeartMate 3 use in younger population Dec 18, 2020
<ѻý>New Valve Disease Guideline: Rethinking TAVR vs SAVR, MitraClip Indicationsѻý> PARTNER 3, Evolut Low Risk, COAPT trials make their mark Dec 17, 2020
<ѻý>FDA Panel Backs Entresto, Spironolactone for Broader HF Useѻý> But committee stops short of advocating categorical approval for HFpEF Dec 16, 2020
<ѻý>FDA Review Gives Rosy Outlook for What Could Be First HFpEF Drugsѻý> Advisory committee weigh unusual moves for Entresto and spironolactone Dec 14, 2020